Fomina, D. (2020) “Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia”, Pathogens and Immunity. Cleveland, Ohio, United States, 5(1), pp. 327–341. doi: 10.20411/pai.v5i1.392.